Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.58 USD
Change Today +0.0497 / 9.37%
Volume 277.2K
ONCY On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Matthew C. Coffey Ph.D.

Chief Operating Officer and Director,Oncolytics Biotech Inc.
AgeTotal Calculated CompensationThis person is connected to 20 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Matthew C. Coffey, also known as Matt, Ph.D., has been the Chief Operating Officer of Oncolytics Biotech Inc. since December 2008. Dr. Coffey Co-founded and served as Vice President of Product Development from July 1999 to December 2004 and Chief Financial Officer of Oncolytics Biotech Inc., from September 1999 to May 2000 and Project Manager of SYNSORB from March 1999 to July 1999. He served as the Chief Scientific Officer of Oncolytics Biotech Inc. from December ...

Read Full Background

Corporate Headquarters*

1167 Kensington Crescent, NW
Calgary, Alberta T2N 1X7


Phone: 403-670-7377
Fax: 403-283-0858

Board Members Memberships*

Chief Operating Officer and Director


University Of Calgary

Other Affiliations*

Annual Compensation*

Total Annual CompensationC$370,475

Stock Options*

All Other CompensationC$54,950
Total Number of Options1,372,666

Total Compensation*

Total Annual Cash CompensationC$425,425
Total Short Term CompensationC$370,475
Other Long Term CompensationC$54,950
Total Calculated CompensationC$425,425
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ONCY:US $0.58 USD +0.0497


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOLYTICS BIOTECH INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at